Emerald Mutual Fund Advisers Trust’s Twist Bioscience TWST Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.86M	Buy	18,050 +200	+1%	+$13K	0.07%	134
2026 Q1	$848K	Buy	+17,850	New	+$800K	0.04%	149
2021 Q4	–	Sell	-26,698	Closed	-$2.86M	–	232
2021 Q3	$2.86M	Hold	26,698	–	–	0.1%	149
2021 Q2	$3.56M	Sell	26,698 -19,593	-42%	-$2.28M	0.12%	144
2021 Q1	$5.73M	Sell	46,291 -79,100	-63%	-$12M	0.19%	127
2020 Q4	$17.7M	Sell	125,391 -252,944	-67%	-$28.1M	0.62%	69
2020 Q3	$28.7M	Sell	378,335 -41,570	-10%	-$2.59M	1.27%	20
2020 Q2	$19M	Sell	419,905 -5,750	-1%	-$206K	0.9%	46
2020 Q1	$13M	Buy	425,655 +110,898	+35%	+$2.98M	0.82%	45
2019 Q4	$6.61M	Sell	314,757 -209,336	-40%	-$4.9M	0.27%	118
2019 Q3	$12.5M	Hold	524,093	–	–	0.55%	62
2019 Q2	$15.2M	Buy	524,093 +319,373	+156%	+$8.45M	0.6%	61
2019 Q1	$4.75M	Buy	204,720 +69,696	+52%	+$1.57M	0.19%	147
2018 Q4	$3.12M	Buy	+135,024	New	+$2.99M	0.15%	162

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's TWST Position: Q2 2026 in Review

Emerald Mutual Fund Advisers Trust increased its Twist Bioscience (TWST) stake by 1.1% in Q2 2026, buying an estimated $13K and bringing the position to 18,050 shares worth $1.86M. The position accounts for 0.07% of the portfolio, ranked #134.

Emerald Mutual Fund Advisers Trust first reported a position in TWST in Q4 2018 and has held it in 14 quarters since. The position peaked at $28.7M in Q3 2020. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Emerald Mutual Fund Advisers Trust held 18,050 shares of Twist Bioscience worth $1.86M as of Q2 2026.
Emerald Mutual Fund Advisers Trust bought 200 Twist Bioscience shares in Q2 2026, an estimated $13K.
Twist Bioscience made up 0.07% of Emerald Mutual Fund Advisers Trust's portfolio in Q2 2026, its #134 holding.
Emerald Mutual Fund Advisers Trust first reported a position in Twist Bioscience in Q4 2018 and has held it in 14 quarters since.
Emerald Mutual Fund Advisers Trust's Twist Bioscience position peaked at $28.7M in Q3 2020.
335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2026, filed 5 Aug 2026.